Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management. Paytm Payments Bank’s license cancellation has limited impact on its core business. Banks show stable earnings with upside potential, while NBFCs face stretched valuations. Consumption and select sectors present opportunities.
